Alloimmune Response Monitoring
Alloimmune Response Monitoring - Related Videos
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
0 Views •
Cited by 7 •
2015
We describe a protocol for aortic interposition grafting in mice. The goal of the protocol is to provide a model with which to study pathological processes and therapeutic strategies relevant to alloimmune reactions in arteries and the resultant arterial changes that contribute to organ transplant failure.
11:01
Monitoring Plant Hormones During Stress Responses
0 Views •
Cited by 11 •
2009
A simple method is provided that allows for the rapid extraction and analysis of multiple plant hormones from small tissue samples. The procedure uses vapor phase extraction as the solemn purification step. Samples are analyzed by GC/MS with chemical ionization that produces mainly (M+1)+ ions.
08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
0 Views •
Cited by 14 •
2017
The method described here allows for the visualization of IL-8 promoter-dependent inflammation activation in the lungs of mice through non-invasive bioluminescence imaging (BLI). The same animal can be subjected to BLI multiple times for up to two months from the time of delivery of the luciferase reporter construct.
05:40
A Mouse Aortic Interposition Model to Study Alloimmune-Induced Vascular Rejection
0 Views •
2025
This video demonstrates a method for generating a mouse aortic interposition model to study alloimmune-induced vascular rejection. After placing an anesthetized donor mouse in the supine position, the infrarenal abdominal aorta (IAA) is carefully isolated from surrounding structures. Branching vessels are ligated, and both ends of the IAA are clamped to prevent blood flow before resection. Subsequently, the donor IAA is implanted into an allogeneic recipient mouse, and blood flow is restored...
04:18
Monitoring the Brain Cortex with a Multi-Electrode Array in Response to Seizure-Inducing Agents
0 Views •
2025
In this video, the effects of transcranial direct-current stimulation (tDCS) on brain slices containing the anterior cingulate cortex (ACC) and thalamus regions are investigated, using a multi-electrode array (MEA) to measure electric signals. By delivering electric pulses and infusing seizure-inducing drugs, the study investigates the ACC response to seizures.
FAQs
These measurements capture different aspects of recipient immunity. Donor-specific antibodies indicate antibody-directed recognition, whereas alloreactive T-cell assays assess cellular responses; immune biomarkers provide additional signals of activation or change. Combining them can produce a more informative immune profile than relying on one test alone, helping investigators examine whether several indicators point toward increasing graft risk.
A sequence of results shows whether immune activity is stable, increasing, or decreasing over time. This trend-based view is more informative for risk assessment than an isolated measurement because it can reveal emerging activation before severe graft injury becomes apparent. Serial testing also supports evaluation of how the immune profile changes during follow-up or treatment.
Donor-specific antibodies provide evidence that recipient immunity is recognizing donor-related targets. When tracked over time, their presence or change can contribute to assessment of possible harmful immune activity directed at the graft. They are most useful as one component of a broader monitoring strategy, since antibody results do not represent the full range of cellular and biomarker responses.
Interpretation depends on patterns across repeated immune measurements rather than on a single result. Stable or changing antibody, T-cell, and biomarker findings can be considered alongside the clinical question of graft adaptation or dysfunction. This integrated approach helps researchers investigate whether immune activity is remaining controlled or becoming more consistent with a harmful response.
The workflow generally begins with serial blood collection followed by assays selected to detect donor-specific antibodies, alloreactive T cells, or immune biomarkers. Results are then compared across time to identify meaningful changes in recipient immune activity. Standardized collection and testing are important because consistent procedures make longitudinal patterns easier to interpret and compare.
Researchers use it to support risk stratification, investigate suspected or established rejection, and evaluate the effects of immunosuppressive treatment. Repeated assessments can show whether immune activity is changing during follow-up, providing evidence for studies of graft adaptation and dysfunction. The resulting data may also help inform more timely and individualized clinical decisions.
Blood-based assays can reveal whether the recipient has detectable donor-specific antibodies, measurable alloreactive T-cell activity, or changes in selected immune biomarkers. Together, these findings provide an indirect picture of immune engagement with the graft. They support comparison between time points and can help characterize patterns associated with immune activation or reduced risk.
Within immunology, the approach provides a way to study how recipient immune responses recognize and affect genetically different graft tissue. It also supplies structured measurements for examining rejection, graft adaptation, and treatment response. In the broader immunology and infection research setting, standardized immune profiling can support investigation of immune activity and improve comparison across studies.